Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Ovarian Neoplasms 1Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 111Specimen Handling 106Cyclophosphamide 95Radiotherapy 75pembrolizumab 71Cisplatin 68Nivolumab 66fludarabine 61Carboplatin 60Biopsy 51Radiosurgery 47Paclitaxel 44Radiation 42Standard of Care 40Gemcitabine 37Doxorubicin 36Rituximab 35venetoclax 34Dexamethasone 34Surveys and Questionnaires 31fludarabine phosphate 30Radiotherapy, Intensity-Modulated 30Cytarabine 30durvalumab 27Practice Guidelines as Topic 27Blood Specimen Collection 27Ipilimumab 26Etoposide 25Drug Therapy 25Surgical Procedures, Operative 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × FAPI-46 × 30 days × Clear all
NCT05903807 2026-05-27

[68Ga]Ga-FAPI-46 PET/CT in Ovarian Cancer

Aalborg University Hospital

Phase 2 Terminated
20 enrolled
Gynecologic

Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡